EQUITY

12 Months Ended

Oct. 31, 2015

Notes to Financial Statements

NOTE 5 - EQUITY

On January 14, 2014 the Company sold 510,000 shares of common stock at $0.725 per share to 8 individuals for $369,750 in cash.

On August 15, 2014 the Company sold 798,500 shares of restricted common stock at $1.10 per share to 19 individuals for $878,350 in cash. 38,200 of the shares issued were purchased by related parties of the company. The shares were purchased as part of the private placement for the same purchase price as the other investors.

On November 10, 2015 the Company issued 25,000 shares of common stock at $1.50 per share with a value of $37,250 for services.

On December 4, 2015 the Company sold 78,000 shares of common stock a $1.282 per share to a related party for $100,000 in cash.

On October 31, 2015 the Company issued 81,100 shares of common stock at $1.05 per share to an officer and director of the Company for their contribution of accrued compensation to capital with a value of $85,100.

On July 30, 2015, the Company issued 193,661 shares of Series B convertible preferred stock to three related parties in exchange for the outstanding notes payable and accrued interest of $193,661. The Company reviewed the instruments and determined they did not qualify as a derivative liability under ASC 815 and thus did not calculate a fair value as time of issuance.